loading
Schlusskurs vom Vortag:
$8.07
Offen:
$8.07
24-Stunden-Volumen:
155.02K
Relative Volume:
0.11
Marktkapitalisierung:
$384.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.60M
KGV:
-3.915
EPS:
-2.06
Netto-Cashflow:
$-48.61M
1W Leistung:
-0.19%
1M Leistung:
+1.70%
6M Leistung:
+266.59%
1J Leistung:
+89.76%
1-Tages-Spanne:
Value
$8.06
$8.08
1-Wochen-Bereich:
Value
$8.06
$8.09
52-Wochen-Spanne:
Value
$1.312
$8.10

Vigil Neuroscience Inc Stock (VIGL) Company Profile

Name
Firmenname
Vigil Neuroscience Inc
Name
Telefon
857-254-4445
Name
Adresse
100 FORGE ROAD, WATERTOWN
Name
Mitarbeiter
67
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
VIGL's Discussions on Twitter

Vergleichen Sie VIGL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VIGL
Vigil Neuroscience Inc
8.06 376.17M 0 -82.60M -48.61M -2.06
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.55 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.17 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.15 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
582.84 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.79 31.99B 3.81B -644.79M -669.77M -6.24

Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Herabstufung Stifel Buy → Hold
2024-12-04 Eingeleitet William Blair Outperform
2023-12-19 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-10-18 Eingeleitet JMP Securities Mkt Outperform
2023-03-31 Eingeleitet Mizuho Buy
2022-09-16 Eingeleitet Wedbush Outperform
2022-08-29 Eingeleitet H.C. Wainwright Buy
2022-02-01 Eingeleitet Guggenheim Buy
2022-02-01 Eingeleitet Jefferies Buy
2022-02-01 Eingeleitet Morgan Stanley Equal-Weight
2022-02-01 Eingeleitet Stifel Buy
Alle ansehen

Vigil Neuroscience Inc Aktie (VIGL) Neueste Nachrichten

pulisher
Jul 22, 2025

Vigil Neuroscience Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Vigil Neuroscience Inc. stockFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Vigil Neuroscience Inc. stock priceGame-changing capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Vigil Neuroscience Inc. a good long term investmentStrong return on assets - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period - Investing.com Australia

Jul 17, 2025
pulisher
Jul 15, 2025

How Vigil Neuroscience Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Vigil Neuroscience Inc. stock attracts strong analyst attention10x Potential Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Vigil Neuroscience Inc. stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80 - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc.VIGL - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

TREM2 agonists reported in Vigil Neuroscience patents - BioWorld MedTech

Jul 14, 2025
pulisher
Jul 09, 2025

Vigil Neuroscience (NASDAQ:VIGL) Stock Price Up 0.4% – Here’s What Happened - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: TASK, VIGL, STRM, and CHTR - The Malaysian Reserve

Jul 04, 2025
pulisher
Jun 30, 2025

Vigil Neuroscience Announces Special Meeting for Sanofi Merger Vote - TipRanks

Jun 30, 2025
pulisher
Jun 25, 2025

Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High? - Nasdaq

Jun 25, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet - MSN

Jun 09, 2025

Finanzdaten der Vigil Neuroscience Inc-Aktie (VIGL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Vigil Neuroscience Inc-Aktie (VIGL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Magovcevic-Liebisch Ivana
President and CEO
Dec 19 '24
Buy
1.68
5,000
8,400
222,687
Magovcevic-Liebisch Ivana
President and CEO
Dec 18 '24
Buy
1.67
5,000
8,350
217,687
Magovcevic-Liebisch Ivana
President and CEO
Dec 05 '24
Buy
2.34
5,000
11,700
212,687
$23.56
price up icon 3.00%
$36.17
price up icon 0.52%
$103.23
price down icon 0.15%
$27.77
price down icon 0.86%
$114.09
price down icon 0.58%
biotechnology ONC
$295.00
price up icon 0.05%
Kapitalisierung:     |  Volumen (24h):